Home > Insider Trading > Filing (0001140361-13-034590)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1311596	Regado Biosciences Inc	RGDO	Pharmaceutical Preparations (2834)	030422069

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901066	A Robert Kierlin	2001 Theurer Boulevard Winona MN 55987		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	201,785	$0.00	224,262	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	100,050	$0.00	324,312	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	199,050	$0.00	523,362	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	1,392,875	$0.00	1,916,237	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	634,718	$0.00	2,550,955	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	750,000	$4.00	3,300,955	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series A Preferred Stock	Disposition	2013-08-27	3,369,811	$0.00	201,785	$0.00
Common Stock, Par Value $0.001 Per Share	Series B Preferred Stock	Disposition	2013-08-27	1,670,833	$0.00	100,050	$0.00
Common Stock, Par Value $0.001 Per Share	Series C Preferred Stock	Disposition	2013-08-27	3,324,136	$0.00	199,050	$0.00
Common Stock, Par Value $0.001 Per Share	Series D Preferred Stock	Disposition	2013-08-27	23,261,013	$0.00	1,392,875	$0.00
Common Stock, Par Value $0.001 Per Share	Series E Preferred Stock	Disposition	2013-08-27	10,750,105	$0.00	634,718	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

The shares of Series A Preferred Stock had no expiration date and automatically converted upon the consummation of the initial public offering of Regado Biosciences, Inc. (the "Company") at a conversion ratio of 1 share of Series A Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series B Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series B Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series C Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series C Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series D Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series D Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series E Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.